Document:

Exhibit 10.6.1

 

FIRST LOAN MODIFICATION AGREEMENT

 

This
First Loan Modification Agreement (this “Loan Modification Agreement”) is entered into as of November 14, 2013, by
and among (a) SILICON VALLEY BANK, a California corporation (“SVB”; and in its capacity as Administrative Agent,
the “Agent”), with its principal place of business at 3003 Tasman Drive, Santa Clara, California 95054 with a loan
production office located at 505 Fifth Avenue, 11th Floor, New York, New York 10017, (b) SVB and SILVER LAKE WATERMAN
FUND, L.P., a Delaware limited partnership (“Silver Lake”), with its principal place of business at 2775 Sand
Hill Road, Suite 100, Menlo Park, California 94025 (each a “Lender”, and collectively the “Lenders”),
and (c) EVERYDAY HEALTH, INC., a Delaware corporation (“Everyday Health”), with its principal place of business
at 345 Hudson Street, 16th Floor, New York, New York 10014, EVERYDAY HEALTH MEDIA, LLC, a Delaware limited liability
company (“Media”), with its principal place of business at 345 Hudson Street, 16th Floor, New York, New
York 10014 and MEDPAGE TODAY, L.L.C., a New Jersey limited liability company (“MedPage”), with its principal
place of business at 345 Hudson Street, 16th Floor, New York, New York 10014 (Everyday Health, Media and MedPage are
hereinafter jointly and severally, individually and collectively, referred to as “Borrower”).

 

1. DESCRIPTION OF EXISTING INDEBTEDNESS AND OBLIGATIONS.
Among other indebtedness and obligations which may be owing by Borrower to Lenders, Borrower is indebted to Lenders pursuant to
a loan arrangement dated as of October 22, 2012, evidenced by, among other documents, a certain Subordinated Loan and Security
Agreement dated as of October 22, 2012 (as amended, the “Loan Agreement”). Capitalized terms used but not otherwise
defined herein shall have the same meaning as in the Loan Agreement.

 

2. DESCRIPTION OF COLLATERAL. Repayment of the Obligations
is secured by, among other property, (a) the Collateral, (b) the Intellectual Property Collateral as defined in a certain Intellectual
Property Security Agreement dated as of October 22, 2012, between Everyday Health and Agent (as amended, the “Everyday Health
IP Agreement”), (c) the Intellectual Property Collateral as defined in a certain Intellectual Property Security Agreement
dated as of October 22, 2012, between Media and Agent (as amended, the “Media IP Agreement”), and (d) the Intellectual
Property Collateral as defined in a certain Intellectual Property Security Agreement dated as of October 22, 2012, between MedPage
and Agent (as amended, the “MedPage IP Agreement”) (together with any other collateral security granted to Agent or
Lenders, the “Security Documents”). Hereinafter, the Security Documents, together with all other documents evidencing
or securing the Obligations shall be referred to as the “Existing Loan Documents”.

 

3. DESCRIPTION OF CHANGE IN TERMS.

 

	 	A.	Modifications to Loan Agreement. 

 

	 	1	 The Loan Agreement shall
be amended by deleting the following text, appearing in Section 2.1.1(b) thereof:

 

“Commencing
on the first Payment Date following the Funding Date of the Term Loan Advance, and continuing on each Payment Date thereafter,
Borrower shall make monthly payments of interest, in arrears, on the principal amount of the Term Loan Advance (including the
Term Loan PIK Amount) at the rate set forth in Section 2.2(a).”

 

		 	and inserting in lieu thereof the following:

 

“Commencing
on the first Payment Date following the Funding Date of the Term Loan Advance, and continuing on each Payment Date thereafter,
Borrower shall make monthly payments of interest, in arrears, on the principal amount of

    	1

    	

    

the
Term Loan Advance (including the Term Loan PIK Amount) at the rate set forth in Section 2.2(a)(i).”

 

		2	The Loan Agreement shall be amended by inserting the following
new Section 2.1.2, appearing immediately after Section 2.1.1 thereof:

 

“        
2.1.2 2013     Term Loan Advance.

 

(a)
Availability. Subject to the terms and conditions of this Agreement, on the First LMA Closing Date, each Lender agrees
(jointly and not severally) to make one (1) advance available to Borrower in an amount equal to such Lender’s Commitment
Percentage multiplied by Five Million Dollars ($5,000,000.00) (such advance, plus the 2013 Term Loan PIK Amount, the “2013
Term Loan Advance”). After repayment, the 2013 Term Loan Advance may not be reborrowed.

 

(b)
Interest Payments. Commencing on the first Payment Date following the Funding Date of the 2013 Term Loan Advance, and continuing
on each Payment Date thereafter, Borrower shall make monthly payments of interest, in arrears, on the principal amount of the
2013 Term Loan Advance (including the 2013 Term Loan PIK Amount) at the rate set forth in Section 2.2(a)(ii). In addition, any
portion of interest on the outstanding principal amount of the 2013 Term Loan Advance accruing at the 2013 Term Loan PIK Rate
shall be paid-in-kind by being added to the outstanding principal amount of the 2013 Term Loan Advance and any such interest so
paid-in-kind shall be deemed capitalized on the first (1st) calendar day of each month, and thereafter, the 2013 Term Loan Advance
shall bear interest at the aggregate rate as provided hereunder.

 

(c)
Repayment. All outstanding principal and accrued and unpaid interest with respect to the 2013 Term Loan Advance (including
the 2013 Term Loan PIK Amount), and all other outstanding Obligations with respect to the 2013 Term Loan Advance, are due and
payable in full on the 2013 Term Loan Maturity Date.

 

(d)
Permitted Prepayment. Borrower shall have the option to prepay all, but not less than all, of the 2013 Term Loan Advance,
provided Borrower (i) delivers written notice to Agent of its election to prepay the 2013 Term Loan Advance at least three (3)
days prior to such prepayment, and (ii) pays, on the date of such prepayment (A) all outstanding principal plus accrued and unpaid
interest with respect to the 2013 Term Loan Advance (including the 2013 Term Loan PIK Amount), (B) the 2013 Prepayment Premium,
and (C) all other sums, if any, that shall have become due and payable with respect to the 2013 Term Loan Advance (including the
2013 Term Loan PIK Amount), including interest at the Default Rate with respect to any past due amounts.

 

(e)
Mandatory Prepayment Upon an Acceleration. If the 2013 Term Loan Advance is accelerated by Agent following the occurrence
and during the continuance of an Event of Default, Borrower shall immediately pay to Agent an amount equal to the sum of (i) all
outstanding principal plus accrued and unpaid interest with respect to the 2013 Term Loan Advance (including the 2013 Term Loan
PIK Amount), and (ii) all other sums, if any, that shall have

    	2

    	

    

become due and payable with respect to the 2013 Term Loan Advance
(including the 2013 Term Loan PIK Amount), including interest at the Default Rate with respect to any past due amounts.”

 

		3	The Loan Agreement shall be amended by deleting the following,
appearing as Section 2.2 thereof:

 

“         2.2     Payment of Interest on the Term Loan Advance.

 

(a) Interest Rate. Subject to Section 2.2(b), the principal
amount outstanding for the Term Loan Advance (including the Term Loan PIK Amount) shall accrue interest at the aggregate of (i)
a fixed per annum rate equal to ten and one-half of one percent (10.50%), which interest shall be payable monthly in accordance
with Section 2.2(e) below, plus (ii) the Term Loan PIK Rate, compounded monthly, and payable on the Term Loan Maturity Date.

 

(b) Default Rate. Immediately upon the occurrence and
during the continuance of an Event of Default, Obligations in connection with the Term Loan Advance shall bear interest at a rate
per annum which is three percentage points (3.0%) above the rate that is otherwise applicable thereto (the “Default Rate”).
Fees and expenses which are required to be paid by Borrower pursuant to the Loan Documents (including, without limitation,
Lender Expenses) but are not paid when due shall bear interest until paid at a rate equal to the highest rate applicable to the
Obligations. Payment or acceptance of the increased interest rate provided in this Section 2.2(b) is not a permitted alternative
to timely payment and shall not constitute a waiver of any Event of Default or otherwise prejudice or limit any rights or remedies
of Agent or Lenders.

 

(c)
Computation; 360-Day Year. In computing interest, the date of the making of the Term Loan Advance shall be included and
the date of payment shall be excluded; provided, however, that if the Term Loan Advance is repaid on the same day on which
it is made, such day shall be included in computing interest on the Term Loan Advance. Interest shall be computed on the basis
of a 360-day year for the actual number of days elapsed.

 

(d) Debit of Accounts. Agent may debit any of Borrower’s
deposit accounts, including the Designated Deposit Account, for principal (including the Term Loan PIK Amount) and interest payments
or any other amounts Borrower owes Agent or Lenders when due. These debits shall not constitute a set-off.

 

(e) Interest Payment Date. Unless otherwise provided,
interest is payable monthly on the Payment Date.”

 

		 	and inserting in lieu thereof the following:

 

“        2.2     Payment of Interest on the Term Loan Advance
and the 2013 Term Loan Advance.

 

(a) Interest Rate.

    	3

    	

    

(i) Subject to Section 2.2(b), the principal amount outstanding
for the Term Loan Advance (including the Term Loan PIK Amount) shall accrue interest at the aggregate of (i) a fixed per annum
rate equal to ten and one-half of one percent (10.50%), which interest shall be payable monthly in accordance with Section 2.2(e)
below, plus (ii) the Term Loan PIK Rate, compounded monthly, and payable on the Term Loan Maturity Date.

 

(ii) Subject to Section 2.2(b), the principal amount outstanding
for the 2013 Term Loan Advance (including the 2013 Term Loan PIK Amount) shall accrue interest at the aggregate of (i) a fixed
per annum rate equal to ten and one-half of one percent (10.50%), which interest shall be payable monthly in accordance with Section
2.2(e) below, plus (ii) the 2013 Term Loan PIK Rate, compounded monthly, and payable on the 2013 Term Loan Maturity Date.

 

(b) Default Rate. Immediately upon the occurrence and
during the continuance of an Event of Default, Obligations in connection with the Term Loan Advance and the 2013 Term Loan Advance
shall bear interest at a rate per annum which is three percentage points (3.0%) above the rate that is otherwise applicable thereto
(the “Default Rate”). Fees and expenses which are required to be paid by Borrower pursuant to the Loan Documents
(including, without limitation, Lender Expenses) but are not paid when due shall bear interest until paid at a rate equal to the
highest rate applicable to the Obligations. Payment or acceptance of the increased interest rate provided in this Section 2.2(b)
is not a permitted alternative to timely payment and shall not constitute a waiver of any Event of Default or otherwise prejudice
or limit any rights or remedies of Agent or Lenders.

 

(c) Computation; 360-Day Year. In computing interest,
the date of the making of the Term Loan Advance or the 2013 Term Loan Advance, as applicable, shall be included and the date of
payment shall be excluded; provided, however, that if the Term Loan Advance or the 2013 Term Loan Advance is repaid on
the same day on which it is made, such day shall be included in computing interest on the Term Loan Advance or the 2013 Term Loan
Advance, as applicable. Interest shall be computed on the basis of a 360-day year for the actual number of days elapsed.

 

(d) Debit of Accounts. Agent may debit any of Borrower’s
deposit accounts, including the Designated Deposit Account, for principal (including the Term Loan PIK Amount and the 2013 Term
Loan PIK Amount) and interest payments or any other amounts Borrower owes Agent or Lenders when due. These debits shall not constitute
a set-off.

 

(e) Interest Payment Date. Unless otherwise provided,
interest is payable monthly on the Payment Date.”

 

		4	The Loan Agreement shall be amended by deleting the following
text, appearing in Section 2.3 thereof:

 

“          (b) Prepayment Premium. The Prepayment Premium,
when due hereunder; and

    	4

    	

    

(c) Lender Expenses. All Lender
Expenses (including reasonable attorneys’ fees and expenses for documentation and negotiation of this Agreement) incurred
through and after the Effective Date, when due.”

 

		 	and inserting in lieu thereof the following:

 

“             (b) Prepayment Premium. The Prepayment Premium,
when due hereunder;

 

(c) 2013 Prepayment Premium. The 2013 Prepayment Premium,
when due hereunder; and

 

(d) Lender Expenses. All Lender Expenses (including
reasonable attorneys’ fees and expenses for documentation and negotiation of this Agreement) incurred through and after
the Effective Date, when due.”

 

		5	The Loan Agreement shall be amended by deleting the following
text, appearing in Section 12.1 thereof:

 

“Each Lender may elect to participate all or a portion
of its interest under this Agreement to any Person, at no cost to Borrower and in consultation with and upon notice to Borrower,
provided, however, that if such Person is not a banking, financial institution or other lender in the primary business of making
loans, Borrower must consent to such Person, which consent shall not be unreasonably withheld or delayed (it being acknowledged
by Borrower that Borrower’s consent is not required for a participation by WestRiver Mezzanine Loans, LLC).”

 

		 	and inserting in lieu thereof the following:

 

“In addition to and without limiting the foregoing, each
Lender may elect to participate all or a portion of its interest under this Agreement to any Person, at no cost to Borrower and
in consultation with Borrower, provided, however, that if such Person is not a banking institution, financial institution or other
lender in the primary business of making loans, Borrower must consent to such Person, which consent shall not be unreasonably
withheld or delayed (it being acknowledged by Borrower that Borrower’s consent is not required for a participation by WestRiver
Mezzanine Loans, LLC, and that Lenders have consulted with Borrower in connection with a participation by WestRiver Mezzanine
Loans, LLC).”

 

		6	The Loan Agreement shall be amended by inserting the following
new definitions to appear alphabetically in Section 13.1 thereof:

 

“        “2013 Prepayment Premium” is an
additional fee payable to Agent, for the ratable benefit of Lenders, in an amount equal to, for a prepayment of the 2013 Term
Loan Advance made (a) on or prior to the date that is one (1) year from the Funding Date of the 2013 Term Loan Advance, three
percent (3.0%) of the principal amount of the 2013 Term Loan Advance (including the 2013 Term Loan PIK Amount), (b) after the
date that is one (1) year from the Funding Date of the 2013 Term Loan Advance but on or prior to the date that is two (2) years
from the Funding Date of the 2013 Term Loan Advance, two percent (2.0%) of the principal amount of the 2013 Term Loan Advance
(including the 2013 Term

    	5

    	

    

Loan PIK Amount), and (c) after the date that is two (2) years
from the Funding Date of the 2013 Term Loan Advance, one percent (1.0%) of the principal amount of the 2013 Term Loan Advance
(including the 2013 Term Loan PIK Amount); provided, however, in the event that, prior to December 31, 2014, Everyday Health closes
the initial underwritten offering and sale of its common stock to the public pursuant to an effective registration statement under
the Securities Act of 1933, and the prepayment of the 2013 Term Loan Advance is made within ninety (90) days after such closing,
the 2013 Prepayment Premium shall be one percent (1.0%) of the principal amount of the 2013 Term Loan Advance (including the 2013
Term Loan PIK Amount).”

 

“         “2013 Term Loan Advance” is defined
in Section 2.1.2(a).”

 

“         “2013 Term Loan Maturity Date” is
the date that is thirty-six (36) months from the First LMA Closing Date.”

 

“         “2013 Term Loan PIK Amount” means,
as of any date of determination, the amount of all interest accrued with respect to the 2013 Term Loan Advance that is required
to be paid in kind by being added to the principal balance thereof in accordance with Section 2.2(a)(ii) of this Agreement. The
2013 Term Loan PIK Amount shall be reduced by any payments made by Borrower to Agent toward the 2013 Term Loan PIK Amount for
the prior month only, provided (a) such payment is made with contemporaneous or prior written notice to Agent specifying that
such payment is on account of the 2013 Term Loan PIK Amount and within two (2) days of the last day of such month, and (b) Borrower
has made all other required payments hereunder, including without limitation any principal, and interest otherwise payable hereunder.”

 

“         “2013 Term Loan PIK Rate” means
three and one-half of one percent (3.50%) per annum.”

 

“         “First LMA Closing Date” is November
14, 2013.”

 

		7	The Loan Agreement shall be amended by deleting the following
definitions appearing in Section 13.1 thereof:

 

“         “Credit Extension” is the Term Loan
Advance or any other extension of credit by any Lender for Borrower’s benefit under this Agreement.”

 

“        “Obligations” are Borrower’s
obligations to pay when due any debts, principal (including the Term Loan PIK Amount), interest, Lender Expenses, the Prepayment
Premium, and other amounts Borrower owes Agent or any Lender now or later, whether under this Agreement, the other Loan Documents,
or otherwise, including, without limitation, interest accruing after Insolvency Proceedings begin and debts, liabilities, or obligations
of Borrower assigned to Agent or any Lender and the performance of Borrower’s duties under the Loan Documents.”

 

“         “Term Loan PIK Amount” means, as
of any date of determination, the amount of all interest accrued with respect to the Term Loan Advance that is required to be
paid in kind by being added to the principal balance thereof in accordance with Section 2.2(a) of this Agreement. The Term Loan
PIK Amount shall be reduced by any payments made by Borrower to Agent toward the Term

    	6

    	

    

Loan PIK Amount for the prior month only, provided (a) such
payment is made with contemporaneous or prior written notice to Agent specifying that such payment is on account of the Term Loan
PIK Amount and within two (2) days of the last day of such month, and (b) Borrower has made all other required payments hereunder,
including without limitation any principal, and interest otherwise payable hereunder.”

 

“         “SBA Documents” means that certain
letter agreement, dated as of the date hereof, entered into between Borrower and Silver Lake, SBA Form 1031, SBA Form 652, SBA
Form 480 and any other documents required to be delivered to Silver Lake under the rules and regulations of the Small Business
Administration.”

 

“         “Warrant” is, collectively, (a)
that certain Warrant to Purchase Stock dated as of the Effective Date between Borrower and SVB, (b) that certain Warrant to Purchase
Stock dated as of the Effective between Borrower and Silver Lake, and (c) that certain Warrant to Purchase Stock dated as of the
Effective Date between Borrower and WestRiver Mezzanine Loans, LLC.”

 

			and inserting in lieu thereof the following:

 

“         “Credit Extension” is the Term Loan
Advance, the 2013 Term Loan Advance or any other extension of credit by any Lender for Borrower’s benefit under this Agreement.”

 

“         “Obligations” are Borrower’s
obligations to pay when due any debts, principal (including the Term Loan PIK Amount and the 2013 Term Loan PIK Amount), interest,
Lender Expenses, the Prepayment Premium, the 2013 Prepayment Premium, and other amounts Borrower owes Agent or any Lender now
or later, whether under this Agreement, the other Loan Documents, or otherwise, including, without limitation, interest accruing
after Insolvency Proceedings begin and debts, liabilities, or obligations of Borrower assigned to Agent or any Lender and the
performance of Borrower’s duties under the Loan Documents.”

 

“         “Term Loan PIK Amount” means, as
of any date of determination, the amount of all interest accrued with respect to the Term Loan Advance that is required to be
paid in kind by being added to the principal balance thereof in accordance with Section 2.2(a)(i) of this Agreement. The Term
Loan PIK Amount shall be reduced by any payments made by Borrower to Agent toward the Term Loan PIK Amount for the prior month
only, provided (a) such payment is made with contemporaneous or prior written notice to Agent specifying that such payment is
on account of the Term Loan PIK Amount and within two (2) days of the last day of such month, and (b) Borrower has made all other
required payments hereunder, including without limitation any principal, and interest otherwise payable hereunder.”

 

“         “SBA Documents” means that certain
letter agreement, dated as of the date hereof and as of the First LMA Closing Date, entered into between Borrower and Silver Lake,
SBA Form 1031, SBA Form 652, SBA Form 480 and any other documents required to be delivered to Silver Lake under the rules and
regulations of the Small Business Administration.”

    	7

    	

    

“         “Warrant” is, collectively, (a)
that certain Warrant to Purchase Stock dated as of the Effective Date between Everyday Health and SVB, (b) that certain Warrant
to Purchase Stock dated as of the Effective between Everyday Health and Silver Lake, (c) that certain Warrant to Purchase Stock
dated as of the Effective Date between Everyday Health and WestRiver Mezzanine Loans, LLC, (d) that certain Warrant to Purchase
Stock dated as of the First LMA Closing Date between Everyday Health and SVB, (e) that certain Warrant to Purchase Stock dated
as of the First LMA Closing Date between Everyday Health and Silver Lake, and (f) that certain Warrant to Purchase Stock dated
as of the First LMA Closing Date between Everyday Health and WestRiver Mezzanine Loans, LLC, as each may be amended, modified
or restated from time to time.”

 

		8	The Loan Agreement shall be amended by deleting the Schedule
1 (Lenders and Commitments) that is attached to the Loan Agreement and inserting in lieu thereof the Schedule 1 (Lenders and Commitments) attached hereto as Schedule A.

 

		9	The Loan Agreement shall be amended by amending Exhibit
D thereto to add the Silver Lake Promissory Note attached hereto as Schedule B.

 

4. FEES AND EXPENSES. Borrower shall pay to Agent, for
the ratable benefit of Lenders, a modification fee equal to Fifty Thousand Dollars ($50,000.00) (the “Modification Fee”)
(to be shared between the Lenders as follows: (a) Twenty-Eight Thousand Five Hundred Fifty Dollars ($28,550.00) to SVB and (b)
Twenty-One Thousand Four Hundred Fifty Dollars ($21,450.00) to Silver Lake), which Modification Fee shall be due on the date hereof
and shall be deemed fully earned as of the date hereof. Borrower shall also reimburse Lenders for all legal fees and expenses
incurred in connection with this amendment to the Existing Loan Documents.

 

Borrower has previously paid to Agent a deposit of Twenty-Five
Thousand Dollars ($25,000.00) (the “2013 Good Faith Deposit”) to initiate Agent’s due diligence review process,
which 2013 Good Faith Deposit will be applied to the Modification Fee.

 

5. RATIFICATION OF PERFECTION CERTIFICATES.

 

(a) Everyday Health hereby ratifies, confirms and reaffirms,
all and singular, the terms and disclosures contained in a certain Perfection Certificate dated as of October 22, 2012 executed
and delivered by Everyday Health, and acknowledges, confirms and agrees that the disclosures and information Everyday Health provided
to Agent and Lenders in such Perfection Certificate have not changed, as of the date hereof, except as set forth on Schedule
C hereto.

 

(b) Media hereby ratifies, confirms and reaffirms, all and
singular, the terms and disclosures contained in a certain Perfection Certificate dated as of October 22, 2012 executed and delivered
by Media, and acknowledges, confirms and agrees that the disclosures and information Media provided to Agent and Lenders in such
Perfection Certificate have not changed, as of the date hereof, except as set forth on Schedule C hereto.

 

(c) MedPage hereby ratifies, confirms and reaffirms, all and
singular, the terms and disclosures contained in a certain Perfection Certificate dated as of October 22, 2012 executed and delivered
by MedPage, and acknowledges, confirms and agrees that the disclosures and information MedPage provided to Agent and Lenders in
such Perfection Certificate have not changed, as of the date hereof, except as set forth on Schedule C hereto.

 

6. RATIFICATION OF IP AGREEMENTS.

 

(a) Everyday Health hereby ratifies, confirms and reaffirms,
all and singular, the terms and conditions of the Everyday Health IP Agreement, and acknowledges, confirms and agrees that the
Everyday Health IP

    	8

    	

    

Agreement contains an accurate and complete listing of all
Intellectual Property Collateral, as defined in the Everyday Health IP Agreement (except as set forth on Schedule D
hereto), and shall remain in full force and effect.

 

(b) Media hereby ratifies, confirms and reaffirms, all and
singular, the terms and conditions of the Media IP Agreement, and acknowledges, confirms and agrees that the Media IP Agreement
contains an accurate and complete listing of all Intellectual Property Collateral, as defined in the Media IP Agreement (except
as set forth on Schedule D hereto), and shall remain in full force and effect.

 

(c) MedPage hereby ratifies, confirms and reaffirms, all and
singular, the terms and conditions of the MedPage IP Agreement, and acknowledges, confirms and agrees that the MedPage IP Agreement
contains an accurate and complete listing of all Intellectual Property Collateral, as defined in the MedPage IP Agreement (except
as set forth on Schedule D hereto), and shall remain in full force and effect.

 

7. CONSISTENT CHANGES. The Existing Loan Documents are
hereby amended wherever necessary to reflect the changes described above.

 

8. RATIFICATION OF LOAN DOCUMENTS. Borrower hereby ratifies,
confirms, and reaffirms all terms and conditions of all security or other collateral granted to Agent and Lenders, and confirms
that the indebtedness secured thereby includes, without limitation, the Obligations.

 

9. NO DEFENSES OF BORROWER. Borrower hereby acknowledges
and agrees that Borrower has no offsets, defenses, claims, or counterclaims against Agent or Lenders with respect to the Obligations,
or otherwise, and that if Borrower now has, or ever did have, any offsets, defenses, claims, or counterclaims against Agent or
Lenders, whether known or unknown, at law or in equity, all of them are hereby expressly WAIVED and Borrower hereby RELEASES Agent
and Lenders from any liability thereunder.

 

10. CONTINUING VALIDITY. Borrower understands and agrees
that in modifying the existing Obligations, Agent and Lenders are relying upon Borrower’s representations, warranties, and
agreements, as set forth in the Existing Loan Documents. Except as expressly modified pursuant to this Loan Modification Agreement,
the terms of the Existing Loan Documents remain unchanged and in full force and effect. Agent’s and Lenders’ agreement
to modifications to the existing Obligations pursuant to this Loan Modification Agreement in no way shall obligate Agent or Lenders
to make any future modifications to the Obligations. Nothing in this Loan Modification Agreement shall constitute a satisfaction
of the Obligations. It is the intention of Agent, Lenders and Borrower to retain as liable parties all makers of Existing Loan
Documents, unless the party is expressly released by Agent and Lenders in writing. No maker will be released by virtue of this
Loan Modification Agreement.

 

11. COUNTERSIGNATURE. This Loan Modification Agreement
shall become effective only when it shall have been executed by Borrower, Agent and Lenders.

 

[Signature page follows.]

    	9

    	

    

This Loan Modification Agreement is executed
as of the date first written above.

 

BORROWER:

 

EVERYDAY HEALTH, INC.

 

	By:	/s/ Alan Shapiro	 
	Name:	Alan shapiro	 
	Title:	EVP and General Counsel	 

 

EVERYDAY HEALTH MEDIA, LLC

 

	By:	/s/ Alan Shapiro	 
	Name:	Alan Shapiro	 
	Title:	EVP and General Counsel	 

 

MEDPAGE TODAY, L.L.C.

 

	By:	/s/ Alan Shapiro	 
	Name:	Alan Shapiro	 
	Title:	President	 

 

AGENT:

 

SILICON VALLEY BANK

 

	By:	/s/ Michael
    McMahon	 
	Name:	Michael
    McMahon	 
	Title:	Vice
      President	 

 

LENDERS:

 

SILICON VALLEY BANK

 

	By:	/s/ Michael
    McMahon	 
	Name:	Michael
    McMahon	 
	Title:	Vice
      President	 

 

SILVER LAKE WATERMAN FUND, L.P.,

 

By: Silver Lake Technology Associates Waterman, L.L.C., 

its
General Partner

 

	By:	/s/ Shawn K. O’Neill	 
	Name:	Shawn K. O’Neill	 
	Title:	Managing Director	 

    	10

    	

    

Schedule A

 

Schedule 1

 

Lenders and Commitments

 

With respect to the Term Loan Advance:

 

	Lender	 	Commitment	 	Commitment Percentage
	Silicon Valley Bank	 	$	20,000,000.00	 	57.1428571428571%
	Silver Lake Waterman Fund, L.P.	 	$	15,000,000.00	 	42.8571428571429%
	Total	 	$	35,000,000.00	 	100.00%

 

With respect to the 2013 Term Loan Advance:

 

	Lender	 	Commitment	 	Commitment percentage
	Silicon Valley Bank	 	$	2,855,000.00	 	57.10%
	Silver Lake Waterman Fund, L.P.	 	$	2,145,000.00	 	42.90%
	Total	 	$	5,000,000.00	 	100.00%

    	11

    	

    

Schedule B

 

[Silver Lake Promissory Note]

    	12

    	

    

THIS SECURED PROMISSORY NOTE IS SUBJECT
TO THE TERMS OF A SUBORDINATION AGREEMENT DATED AS OF OCTOBER 22, 2012, AMONG SILICON VALLEY BANK, IN ITS CAPACITY AS THE LENDER
UNDER A LOAN AND SECURITY AGREEMENT, DATED AS OF SEPTEMBER 22, 2010, BY AND AMONG SILICON VALLEY BANK, EVERYDAY HEALTH, INC.,
EVERYDAY HEALTH MEDIA, LLC AND MEDPAGE TODAY, L.L.C., AS AMENDED, SILICON VALLEY BANK, IN ITS CAPACITY AS AGENT AND A SUBORDINATED
LENDER UNDER THE LOAN AGREEMENT (AS DEFINED BELOW) AND SILVER LAKE WATERMAN FUND, L.P.

 

Secured Promissory Note

 

	$2,145,000.00	Dated: November___, 2013

 

FOR VALUE RECEIVED, the undersigned, EVERYDAY
HEALTH, INC., a Delaware corporation (“Everyday Health”), EVERYDAY HEALTH MEDIA, LLC, a Delaware limited liability
company (“Media”), and MEDPAGE TODAY, L.L.C., a New Jersey limited liability company (“MedPage”, and together
with Everyday Health and Media, jointly and severally, individually and collectively, “Borrower”), HEREBY PROMISES
TO PAY, jointly and severally, to the order of SILVER LAKE WATERMAN FUND, L.P. (“Lender”) the principal amount of
Two Million One Hundred Forty Five Thousand Dollars and Zero Cents ($2,145,000.00), which amount is equal to Lender’s Commitment
Percentage of the aggregate outstanding principal balance of the 2013 Term Loan Advance made to Borrower pursuant to the Subordinated
Loan and Security Agreement referred to below (as amended, restated or otherwise modified from time to time, the “Loan Agreement”),
plus interest and all other payments arising under the Loan Agreement with respect to Lender’s Commitment Percentage of
such 2013 Term Loan Advance, on the dates and in the amounts set forth in the Loan Agreement. Capitalized terms used herein and
not otherwise defined have the respective meanings set forth in the Loan Agreement.

 

The cash interest rate per annum for the
2013 Term Loan Advance evidenced by this Note determined in accordance with the Loan Agreement is 10.5%. The 2013 Term Loan PIK
Rate per annum for the 2013 Term Loan Advance determined in accordance with the Loan Agreement is 3.5%. All payments due under
this Note or under the Loan Agreement shall be payable as and when specified in the Loan Agreement.

 

This Note is one of the notes referred to in, and is entitled
to the benefits of, the Subordinated Loan and Security Agreement, dated as of October 22, 2012 among Everyday Health, Media, MedPage,
Agent and the Lenders, as amended, restated, supplemented or otherwise modified from time to time. This Note and the obligation
of Borrower to repay the unpaid principal amount of the 2013 Term Loan Advance, interest on the 2013 Term Loan Advance, premium,
if any, and all other amounts due Agent and Lenders under the Loan Agreement is secured under the Loan Agreement.

 

Presentment for payment, demand, notice of protest and all
other demands and notices of any kind in connection with the execution, delivery, performance and enforcement of this Note are
hereby waived.

 

Borrower shall pay, severally and jointly, all reasonable fees
and expenses, including, without limitation, reasonable attorneys’ fees and costs, incurred by Agent or Lender in the enforcement
or attempt to enforce any of Borrower’s obligations hereunder not performed when due. This Note shall be governed by, and
construed and interpreted in accordance with, the laws of the State of New York.

    	 

    	

    

IN WITNESS WHEREOF, Borrower has caused this Note to be duly
executed by one of its officers thereunto duly authorized on the date hereof.

 

	 	EVERYDAY HEALTH, INC.,
	 	a Delaware corporation
	 	 	 
	 	By:	 
	 	 	 
	 	Name:	 
	 	 	 
	 	Title:	 
	 	 	 
	 	 	 
	 	EVERYDAY HEALTH MEDIA, LLC,
	 	a Delaware limited liability company
	 	 	 
	 	By:	 
	 	 	 
	 	Name:	 
	 	 	 
	 	Title:	 
	 	 	 
	 	 	 
	 	MEDPAGE TODAY, L.L.C.,
	 	a New Jersey limited liability company
	 	 	 
	 	By:	 
	 	 	 
	 	Name:	 
	 	 	 
	 	Title:	 

 

[Signature Page to Secured Promissory
Note]Exhibit 10.7

 

EMPLOYMENT AGREEMENT

 

This Employment
Agreement (the “Agreement”) is entered into effective November 22, 2010 (the “Effective
Date”), by and between Benjamin Wolin (the “Employee”) and Everyday Health,
Inc. (the “Company”).

 

The Company desires
to employ the Employee and, in connection therewith, to compensate the Employee for Employee’s personal services to the
Company; and

 

The Employee wishes
to be employed by the Company and provide personal services to the Company in return for certain compensation.

 

Accordingly, in consideration
of the mutual promises and covenants contained herein, the parties agree to the following:

 

1. Employment
by the Company.

 

1.1 Term.
The term of this Agreement shall commence on the Effective Date, and shall continue through November 22, 2013, unless terminated
prior thereto by either the Company or the Employee as provided in Section 5. If either the Company or the Employee does not wish
to renew this Agreement when it expires at the end of the initial or any renewal term hereof, as hereinafter provided, it or he
shall give written notice in accordance with Section 6.1 below of such intent to the other party at least sixty (60) days
prior to the expiration date. In the absence of such notice, this Agreement shall be renewed on the same terms and conditions
contained herein for a term of one (1) year from the date of expiration. The parties expressly agree that designation of a term
and renewal provisions in this Agreement does not in any way limit the right of the parties to terminate this Agreement at any
time as hereinafter provided. Reference herein to the “Term” of this Agreement shall refer both to the
initial term and any successive term as the context requires.

 

1.2 Position.
Subject to the terms set forth herein, the Company agrees to employ Employee in the position of Chief Executive Officer (“CEO”),
and Employee hereby accepts such employment. During the term of Employee’s employment with the Company, Employee will
devote Employee’s best efforts and substantially all of Employee’s business time and attention to the business of
the Company.

 

1.3 Duties.
Employee will report to the Board of Directors of the Company (the “Board”) and/or such individual
Board members and/or committees designated by the Board, performing such duties as are normally associated with his then current
position and such duties as are assigned to him from time to time, provided such duties are not materially inconsistent with his
position as CEO, subject to the oversight and direction of the Board or its designee. Employee shall perform his duties under
this Agreement principally out of the Company’s corporate headquarters. In addition, the Employee shall make such business
trips to such places as may be necessary or advisable for the efficient operations of the Company.

 

1.4 Company
Policies and Benefits. The employment relationship between the parties shall also be subject to the Company’s personnel
policies and procedures as they may be interpreted, adopted, revised or deleted from time to time in the Company’s sole
discretion.

    	 

    	

    

The Employee will be eligible to participate
on the same basis as similarly situated employees in the Company’s benefit plans in effect from time to time during his
employment. All matters of eligibility for coverage or benefits under any benefit plan shall be determined in accordance with the
provisions of such plan. The Company reserves the right to change, alter, or terminate any benefit plan in its sole discretion.
Notwithstanding the foregoing, in the event that the terms of this Agreement differ from, or are in conflict with, the Company’s
general employment policies or practices, this Agreement shall control. While this Agreement is in effect the Employee shall be
eligible to accrue and use five (5) weeks of paid vacation per annum, such vacation to be accrued and administered pursuant to
the Company’s vacation policy.

 

2. Compensation.

 

2.1 Salary.
Employee shall receive for Employee’s services to be rendered hereunder an initial annualized base salary of $375,000, subject
to review and increase from time to time by the Board in its sole discretion, and payable subject to standard federal and state
payroll withholding requirements in accordance with Company’s standard payroll practices  (“Base Salary”).

 

2.2 Bonus.

 

(a) During
Employment. Employee shall be eligible for an annual calendar year bonus (the “Annual Bonus”),
with a target of 100% of his then current Base Salary. The amount of the actual bonus awarded, if any, will be determined by the
Board in its sole discretion based on the Employee’s continuous performance of services to the Company through the date
the Annual Bonus is paid and upon achievement of Company performance objectives and individual performance objectives, such objectives
as set by the Board. The 2010 objectives have been set and have been communicated to the Employee. A bonus earned pursuant to
this Section 2.2(a) will be paid on or before March 15 of the year following the year for which it is earned.

 

(b) Upon
Termination. In the event Employee leaves the employ of the Company for any reason prior to payment of any Annual Bonus,
he is not eligible for an Annual Bonus, prorated or otherwise, except as a component of severance as provided in Section 5 below.

 

2.3 Expense Reimbursement.
The Company will reimburse Employee for reasonable business expenses in accordance with the Company’s standard expense
reimbursement policy.

    	2

    	

    

3. Confidential
Information, Inventions, Company Property, Non-Solicitation, and Non-Competition Obligations

 

3.1 Confidential Information and Return
of Company Property.

 

(a) Employee
shall hold in strict confidence and shall not, either during the term of this Agreement or after the termination hereof, disclose,
directly or indirectly, to any third party, person, firm, corporation or other entity, irrespective of whether such person or
entity is a competitor of the Company or is engaged in a business similar to that of the Company, any Confidential Information
(as define in Section 3.3) of the Company or any subsidiary or Affiliate (as defined in Section 3.3) of the Company obtained or
developed by the Employee from, through, or in the course of Employee’s employment hereunder.

 

(b) Notwithstanding
the foregoing limitations, the Employee shall not be required to keep confidential any information that: (i) is known or available
through other lawful sources, or (ii) is or becomes Publicly Known or generally known in the industry through no fault of the
Employee, Employee’s agents or another individual or entity that owes a duty of confidentiality to the Company, or (iii)
is required to be disclosed pursuant to any statutes, laws, rules, regulations, ordinances, codes, directives, writs, injunctions,
decrees, judgments, and orders of any governmental body (provided the Company is given reasonable prior notice).

 

(c) At any
time requested by the Company and/or at termination of the Employee’s employment for any reason, Employee will promptly
deliver to the Company or permanently destroy all property and materials in any form belonging to or relating to the Company,
its business and the business of any of its Customers or Potential Customers (as defined in Section 3.3) (the “Company
Property”). Following such request by the Company or termination of employment, the Employee shall not download
or keep copies of Company Property in any hard or soft format and shall certify in writing that all Company Property has been
returned to the Company or permanently destroyed.

 

(d) Employee
shall not publicly disparage the Company, its business or its employees.

 

3.2 Non-Competition and Non-Solicitation
Agreement. Employee agrees that, during Employee’s employment hereunder, and for a period of one (1) year (the “Non-Compete Period”) after the later of the effective date of termination of this Agreement, or the date of entry by
a court of competent jurisdiction of a final judgment enforcing this covenant, Employee will not, as an officer, director, employee,
consultant, owner, partner, or in any other capacity, either directly or through others, in any location where the Company has
engaged in business, without the written approval of the Board:

 

(a) solicit,
contact, perform or offer to perform Conflicting Services (as defined in Section 3.3);

 

(b) request,
induce, or attempt to induce any Customer or Potential Customer to terminate or reduce its relationship with the Company or any
subsidiary or

    	3

    	

    

Affiliate of the Company, solicit, contact,
perform or offer to or perform any Conflicting Services for a Customer or Potential Customer.

 

(c) interfere
with or disrupt, or attempt to interfere with or disrupt, the relationship, contractual or otherwise, between the Company, or any
subsidiary or Affiliate of the Company, and any customer, vendor, licensor, supplier or employee of the Company or any subsidiary
or Affiliate of the Company;

 

(d) offer employment
to any person who is a then current employee of the Company or any subsidiary or Affiliate of the Company or has left the Company
or any subsidiary or Affiliate of the Company in the preceding three (3) months, or solicit (directly or indirectly, individually
or in connection with any new employer or other business partner) any person who is a then current employee of the Company or
any subsidiary or Affiliate of the Company or has left the Company or any subsidiary or Affiliate in the preceding three (3) months
to accept employment elsewhere.

 

3.3 Defined Terms. The following
terms shall have the meanings set forth below:

 

(a) “Affiliate”
means any person, firm or corporation, directly or indirectly through one or more intermediaries, controlling, controlled by or
under common control with the Company.

 

(b) “Confidential
Information” means any information used by or belonging or related to the company or any of its affiliates that
is not known generally to the industry in which the Company is or may be engaged and which the Company maintains on a confidential
basis including without limitation any and all intellectual property, trade secrets and proprietary information, information relating
to the Company’s business and services, employee information, customer lists and records, business processes, procedures
or standards, know-how, technology, business strategies, records, financial information, in each case whether or not reduced to
writing or stored electronically, as well as any information that the Company advises the Employee should be treated as confidential
information (including information conceived, discovered or developed by Employee), that he learns of, possesses, or to which
he has access through his employment by the Company, related to the Company, its business partners, or the business of its Customers
or Potential Customers. Confidential Information shall not include information known to Employee prior to his employment with
the Company. Confidential Information shall not include Company information which is or becomes Publicly Known through no breach
of this Agreement or other act or omission of the Employee. The burden of proving that information or skills and experience are
not Confidential Information shall be on the party asserting such exclusion.

 

(c) “Conflicting
Services” means any product, service or process of any person or organization other than the Company, which directly
competes with a product, service or process with which the Employee works during employment by the Company or about which the
Employee acquires Confidential Information during Employee’s employment by the Company.

    	4

    	

    

(d) “Customer
or Potential Customer” means each and every person and/or entity who or which, at any time during the two (2) years
prior to termination of Employee’s employment whom or which the Employee knew or should have been aware: (i) contracted
for, was billed for, or received services from the Company, or (ii) was in contact with the Employee or in contact with another
representative of the Company concerning the Company’s products and services.

 

(e) “Publicly
Known” shall mean readily accessible to the public in a written publication, and shall not include information which
is only available by a substantial searching of the published literature, and information the substance of which must be
pieced together from a number of different publications and sources.

 

3.4 Assignment and Disclosure of Inventions.

 

(a) From and
after the date the Employee first became employed with the Company, the Employee hereby agrees to promptly disclose in confidence
to the Company all inventions, improvements, designs, original works of authorship, formulas, processes, compositions of matter,
computer software programs, databases, mask works, and trade secrets (“Inventions”), whether or not
patentable, copyrightable or protectable as trade secrets, that are made or conceived or first reduced, to practice or created
by the Employee, either alone or jointly with others, during the period and in the course of the Employee’s employment and
which relate in any way to the business of the Company.

 

(b) Employee
hereby acknowledges that copyrightable works prepared by the Employee within the scope of the Employee’s employment are
“works for hire” under the United States Copyright Act and that the Company will be considered the author thereof.
The Employee hereby agrees that all Inventions that (a) are developed using equipment, supplies, facilities or trade secrets of
the Company, (b) result from work performed by the Employee for the Company, or (c) relate to the Company’s business or
current or anticipated research and development, will be the sole and exclusive property of the Company and are hereby assigned
by the Employee to the Company.

 

(c) Employee
agrees to assign and does hereby assign to the Company or its designee all Employee’s right, title and interest in and to
all Inventions related to the business of the Company from time-to-time (whether past, present, or future) and all related patents,
patent applications, copyrights and copyright applications. However, this Section 3.4(c) shall not apply to Inventions which
do not relate to the present or planned business or research and development of the Company and which are not made and conceived
by the Employee during normal working hours, on the Company’s premises and/or using the Company’s tools, devices,
equipment or proprietary information. The Employee understands that, to the extent this Agreement shall be construed in accordance
with the laws of any state which precludes a requirement in an employee agreement to assign certain classes of inventions made
by an employee, this Section 3.4(c) shall be interpreted not to apply to any invention which a court of competent jurisdiction
rules and/or the Company agrees falls within such classes. The Employee also hereby expressly waives all claims to moral rights
in any Inventions.

    	5

    	

    

(d) Employee
agrees to cooperate fully with the Company, both during and after Employee’s employment with the Company, with respect to
the procurement, maintenance and enforcement of copyrights, patents and other intellectual property rights (both in the United
States and foreign countries) relating to Inventions. The Employee shall sign all papers, including, without limitation, copyright
applications, patent applications, declarations, oaths, formal assignments, assignments of priority rights, and powers of attorney,
which the Company may deem necessary or desirable in order to protect its rights and interests in any Development. The Employee
further agrees that if the Company is unable, after reasonable effort, to secure the signature of the Employee on any such papers,
any Employee officer of the Company shall be entitled to execute any such papers as the agent and the attorney-in-fact of the
Employee, and the Employee hereby irrevocably designates and appoints each Employee officer of the Company as Employee’s
agent and attorney-in-fact to execute any such papers on Employee’s behalf, and to take any and all actions as the Company,
in its sole discretion, may deem necessary or desirable in order to protect its rights and interests in any Invention, under the
conditions described in this sentence.

 

3.5 Publication of Covenants to Subsequent
Employers or Business Associates of Employee. Employee agrees that if Employee is offered employment or the opportunity
to enter into any business venture as owner, partner, consultant or other capacity in a business while the covenants in Section
3 of this Agreement are in effect, Employee will inform Employee’s potential employer, partner, co-owner and/or others involved
in managing the business which Employee had an opportunity to join of the existence of this Agreement and will provide such person
or persons with a copy of this Agreement. Employee authorizes the Company to provide copies of this Agreement to any of the persons
or entities described above and to make such persons aware of Employee’s obligations under this Agreement.

 

3.6 Injunctive Relief from Violation
of Section 3. Employee recognizes that irreparable damage will result to the Company in the event of the violation of
any covenant contained in Section 3 and agrees that in the event of such violation, the Company shall be entitled, in addition
to its other legal or equitable remedies and damages, to temporary and permanent injunctive relief to restrain against such violation(s)
thereof by Employee and by all other persons acting for or with Employee, including the cost of reasonable attorney’s fees.

 

3.7 Reasonableness
      of Restrictions.
Employee and the Company agree that they have attempted to restrict Employee’s
activities to a reasonable degree appropriate to protect the interests of the
Company, although they agree that others may disagree about this determination.
Therefore, Employee and the Company agree that a court or other trier of fact,
may modify and enforce these restrictions to the minimum extent deemed necessary
to be found reasonable. If a court declines to modify and enforce this Agreement
as provided above, the Employee and the Company agree that this Agreement will
be automatically modified to provide the Company with the maximum protection
of its business interests allowed by law and the Employee agrees to be bound
by this Agreement as modified. Employee further acknowledges and agrees that
if such Employee’s employment is terminated with or without Cause, Employee’s
experience and capabilities are such that Employee can obtain employment in businesses
engaged in other lines and/or of a different nature, and that enforcement of
the restrictions in this agreement by restraining order, injunction or otherwise
will not prevent Employee from earning a livelihood or cause Employee irreparable
harm.

    	6

    	

    

3.8 Survival. The provisions
of Section 3 of this Agreement shall survive the termination of Employee’s employment with the Company and the termination
of this Agreement.

 

4. Outside
Activities. Except with the prior written consent of the Company’s
Board, Employee will not, while employed by the Company, undertake or engage in any other employment, occupation or business enterprise
that would interfere with Employee’s responsibilities and the performance of Employee’s duties hereunder.

 

5. Termination
Of Employment. The
parties acknowledge that either Employee or the Company may terminate the employment relationship at any time, with or without
Cause or Good Reason. The provisions in this Section govern the amount of compensation, if any, to be provided to Employee upon
termination of employment and do not limit the right of either party to terminate this Agreement.

 

5.1 Termination by the Company Without
Cause.

 

(a) The
Company shall have the right to terminate Employee’s employment with the Company pursuant to this Section 5.1 at any
time without “Cause” (as defined in Section 5.2(b) below) by giving notice as described in Section 5.6 of this
Agreement. A termination pursuant to Section 5.5 below is not a termination without “Cause” for purposes of
receiving the benefits described in this Section 5.1. If the Company provides written notice to the Employee pursuant to
Section 1.1 of its intent not to renew this Agreement, then the expiration of this Agreement shall be considered a
termination without Cause.

 

(b) In the
event Employee’s employment is terminated without Cause, pursuant to the Company’s standard payroll policies, the
Company shall pay to Employee the accrued but unpaid salary of Employee through the date of termination, together with all compensation
and benefits payable to Employee based on his participation in any compensation or benefit plan, program or arrangement through
the date of termination. Provided that Employee’s termination without Cause constitutes a Separation From Service (as defined
below), and provided the Employee executes a general release in favor of the Company, in a form acceptable to the Company (the
“Release”), and subject to Section 5.1(c) (the date that the Release becomes effective and may no longer
be revoked by the Employee is referred to as the “Release Date”), then the Company shall (i) pay to
Employee an amount equal to the sum of (A) Employee’s then current Base Salary for a period of twelve (12) months from the
date of Separation From Service (such applicable period is referred to as the “Severance Period”) plus
(B) an amount equal to Employee’s target bonus, less applicable withholdings and deductions, with such sum paid in equal
installments on the Company’s regular payroll dates running from the Separation From Service; provided, however, that no
payments will be made prior to the day that is sixty (60) days following the date of Separation From Service, and on such date,
the Company will make the first payment to Employee under this Section 5.1(b)(i), in a lump sum, equal to the aggregate amount
of salary continuation that the Company would have paid to Employee through such date had the payments commenced on the Separation
From Service through such 60th day, with the balance paid thereafter on the schedule described above; (ii) Employee
shall be credited with an additional year of service

    	7

    	

    

credit from the date of termination for
purposes of vesting any outstanding equity awards; and (iii) if Employee is participating in the Company’s employee group
health insurance plans on the effective date of termination, and timely elects and remains eligible for continued coverage under
COBRA, or, if applicable, state or local insurance laws, the Company shall pay to Employee, on the first day of each month, a
fully taxable cash payment equal to the applicable COBRA premiums for that month (including premiums for Employee and his eligible
dependents who have elected and remain enrolled in such COBRA coverage), subject to applicable tax withholdings (such amount,
the “Special Cash Payment”), for a number of months equal to the lesser of (i) the duration of the period
in which Employee and his eligible dependents are enrolled in such COBRA coverage (and not otherwise covered by another employer’s
group health plan) and (ii) twelve (12) months. Employee may, but is not obligated to, use such Special Cash Payment toward the
cost of COBRA premiums. On the 60th day following Employee’s Separation From Service, the Company will make the
first payment to Employee under this Section 5.1(b)(ii), in a lump sum, equal to the aggregate Special Cash Payments that the
Company would have paid to Employee through such date had the Special Cash Payments commenced on the first day of the first month
following the Separation From Service through such 60th day, with the balance of the Special Cash Payments paid thereafter
on the schedule described above. In the event Employee becomes covered under another employer’s group health plan or otherwise
ceases to be eligible for COBRA during the period provided in this Section 5.1(b)(ii), Employee must immediately notify the Company
of such event and the Company shall cease payment of the Special Cash Payments.

 

(c) Employee
shall not receive any of the benefits pursuant to Section 5.1(b) unless he executes the Release within the consideration period
specified therein, which shall in no event be more than 45 days, and until the Release becomes effective and can no longer be
revoked by Employee under its terms. In all cases, the Release must be signed and effective not later than the 60th
day following Employee’s Separation From Service. Employee’s ability to receive benefits pursuant to Section 5.1(b)
is further conditioned upon his: complying with his termination and post-termination obligations under this Agreement and any
other agreements between Employee and the Company and complying with the Release including without limitation any confidentiality
provisions contained therein.

 

(d) The benefits
provided to Employee pursuant to this Section 5.1 are in lieu of, and not in addition to, any benefits to which Employee may otherwise
be entitled under any Company severance plan, policy or program.

 

(e) The damages
caused by the termination of Employee’s employment without Cause would be difficult to ascertain; therefore, the severance
for which Employee is eligible pursuant to Section 5.1(b) above in exchange for the Release is agreed to by the parties as liquidated
damages, to serve as full compensation, and not a penalty.

    	8

    	

    

5.2 Termination by the Company for
Cause.

 

(a) Subject
to Section 5.2(c) below, the Company shall have the right to terminate Employee’s employment with the Company at any time
for Cause by giving notice as described in Section 5.6 of this Agreement.

 

(b)
“Cause” for termination shall mean that the Company has determined in its sole discretion that the
Employee has engaged in any of the following: (i) a material breach of any covenant or condition under this Agreement or any
other written agreement between the parties; (ii) any act constituting material dishonesty, fraud, or disreputable conduct or
moral turpitude; (iii) any conduct which constitutes a felony under applicable law; (iv) violation of any Company policy or
any act of misconduct in either case causing harm to the Company or its reputation; (v) refusal to follow or implement a
clear and lawful directive of the Board; (vi) gross negligence or gross incompetence in the performance of Employee’s
duties to the Company; or (vii) breach of fiduciary duty, provided that if Cause is based on the occurrence of one or more of
the events specified in Section 5.2(b)(i), (v) or (vi) of this Agreement, and the Company deems the circumstance constituting
Cause to be curable, the Company will give the Employee written notice as described in Section 5.6 of this Agreement that the
Company intends to terminate the Employee’s employment for Cause on the thirtieth (30th) day following the
Employee’s receipt of the Company’s notice, if the Employee has not cured the circumstances constituting Cause
before the end of such thirty (30) day period.

 

(c) In the
event Employee’s employment is terminated at any time for Cause, Employee will not receive severance payments, or any other
severance compensation or benefit, except that, pursuant to the Company’s standard payroll policies, the Company shall pay
to Employee the accrued but unpaid salary of Employee through the date of termination, together with all compensation and benefits
payable to Employee based on his participation in any compensation or benefit plan, program or arrangement through the date of
termination.

 

5.3 Resignation by the Employee.

 

(a) Employee
may resign from Employee’s employment with the Company at any time by giving notice as described in Section 5.6. If the
Employee provides written notice to the Company pursuant to Section 1.1 of his intent not to renew this Agreement, then the expiration
of this Agreement shall be considered a resignation without Good Reason.

 

(b) In the
event Employee resigns from Employee’s employment with the Company (other than for Good Reason as set forth in Section 5.4),
Employee will not receive severance payments, or any other severance compensation or benefit, except that, pursuant to the Company’s
standard payroll policies, the Company shall pay to Employee the accrued but unpaid salary of Employee through the date of resignation,
together with all compensation and benefits payable to Employee through the date of resignation under any compensation or benefit
plan, program or arrangement during such period and Employee shall

    	9

    	

    

be eligible for any benefit continuation
or conversion rights provided by the provisions of a benefit plan or by law.

 

5.4 Resignation by the Employee for
Good Reason.

 

(a) Provided
Employee has not previously been notified of the Company’s intention to terminate Employee’s employment, the Employee
may resign from employment with the Company for Good Reason (as defined in Section 5.4(b) below), within ten (10) days after
the occurrence of one of the events specified in Section 5.4(b) below, by giving notice as described in Section 5.6 of this Agreement
that Employee intends to terminate his employment for Good Reason on the thirtieth (30) day following the Company’s receipt
of Employee’s notice, if the Company has not cured the event that gives rise to Good Reason before the end of such thirty
(30) day period.

 

(b) “Good
Reason” for resignation shall mean the occurrence of any of the following without the Employee’s prior written
consent: (i) the assignment to Employee of any duties or responsibilities which result in the material diminution of Employee’s
then current position; (ii) a material reduction by the Company in Employee’s annual base salary; or (iii) relocation of
the Employee’s principal place of business more than thirty-five (35) miles from its then current location. Notwithstanding
the foregoing, any actions taken by the Company to accommodate a disability of the Employee or pursuant to the Family and Medical
Leave Act shall not be a Good Reason for purposes of this Agreement.

 

(c) In the
event Employee resigns from Employee’s employment for Good Reason, pursuant to the Company’s standard payroll policies,
the Company shall pay to Employee the accrued but unpaid salary of Employee through the date of termination, together with all
compensation and benefits payable to Employee based on his participation in any compensation or benefit plan, program or arrangement
through the date of termination and, subject to Section 5.4(d), and provided Employee’s resignation constitutes a Separation
From Service, the Employee shall be eligible for the same payments and benefits as Employee would receive under Section 5.1 and
on the same conditions as if Employee had been terminated by the Company without Cause, provided that Employee executes
a Release of claims in favor of the Company as defined in Section 5.1(b).

 

(d) Employee
shall not receive any of the benefits pursuant to Section 5.4(c) unless he executes the Release within the consideration period
specified therein, which shall in no event be more than 60 days, and until the Release becomes effective and can no longer be
revoked by Employee under its terms. In all cases, the Release must be signed and effective not later than the 60th
day following Employee’s Separation From Service. Employee’s ability to receive benefits pursuant to Section 5.4(c)
is further conditioned upon his: returning all Company property; complying with his post-termination obligations under this Agreement
and any other agreements between Employee and the Company, and complying with the Release including without limitation any confidentiality
provisions contained therein.

    	10

    	

    

(e) The benefits
provided to the Employee pursuant to this Section 5.4 are in lieu of, and not in addition to, any benefits to which Employee may
otherwise be entitled under any Company severance plan, policy or program.

 

(f) The damages
caused by the termination of Employee’s employment without Cause would be difficult to ascertain; therefore, the severance
for which Employee is eligible pursuant to Section 5.4(c) above in exchange for the Release is agreed to by the parties as liquidated
damages, to serve as full compensation, and not a penalty.

 

5.5 Termination by Virtue of Death
or Disability of the Employee.

 

(a) In
the event of Employee’s death while employed pursuant to this Agreement, all obligations of the parties hereunder shall
terminate immediately, the Employee’s legal representatives shall not be eligible to receive severance payments, or any
other severance compensation or benefit, except that the Company shall, pursuant to the Company’s standard payroll
policies, pay to the Employee’s legal representatives Employee’s accrued but unpaid salary through the date of
death together with all compensation and benefits payable to Employee based on his participation in any compensation or
benefit plan, program or arrangement through the date of termination.

 

(b) Subject
to applicable state and federal law, the Company shall at all times have the right, upon written notice to the Employee, to terminate
this Agreement based on the Employee’s Disability (as defined below). Termination by the Company of the Employee’s
employment based on “Disability” shall mean termination because the Employee is unable due to a physical
or mental condition to perform the essential functions of his position with or without reasonable accommodation for six (6) months
in the aggregate during any twelve (12) month period or based on the written certification by two licensed physicians of the likely
continuation of such condition for such period. This definition shall be interpreted and applied consistent with the Americans
with Disabilities Act, the Family and Medical Leave Act, and other applicable law. In the event Employee’s employment is
terminated based on the Employee’s Disability, Employee will not receive severance payments, or any other severance compensation
or benefit, except that, pursuant to the Company’s standard payroll policies, the Company shall pay to Employee the accrued
but unpaid salary of Employee through the date of termination, together with all compensation and benefits payable to Employee
based on his participation in any compensation or benefit plan, program or arrangement through the date of termination.

 

5.6 Notice; Effective Date of Termination.

 

(a) Termination
of Employee’s employment pursuant to this Agreement shall be effective on the earliest of:

 

(i) immediately
after the Company gives notice to Employee of Employee’s termination, with or without Cause, unless the Company specifies
a later date, in which case, termination shall be effective as of such later date or, if the Company is obligated under Section
5.2(b) to provide prior notice, thirty (30) days after the Company gives written notice to the Employee of his termination for
Cause unless the Employee has cured the

    	11

    	

    

circumstances constituting Cause (if curable)
on or before that date;

 

(ii) immediately
upon the Employee’s death;

 

(iii) ten (10) days after the Company gives notice to Employee of Employee’s termination on account of Employee’s Disability,
unless the Company specifies a later date, in which case, termination shall be effective as of such later date, provided that
Employee has not returned to the full time performance of Employee’s duties prior to such date; or

 

(iv) ten (10) days after the Employee gives written notice to the Company of Employee’s resignation without good reason, provided
that the Company may set a termination date at any time between the date of notice and the date of resignation, in which case
the Employee’s resignation shall be effective as of such other date. Employee will receive compensation through any required
notice period.

 

(v) thirty
(30) days after Employee gives written notice to the Company of Employee’s resignation for Good Reason unless the Company
has cured the circumstances constituting Good Reason on or before that date;

 

(b) In the
event notice of a termination under subsections (a)(i) or (iii) is given orally, at the Employee’s request, the Company
must provide written confirmation of such notice within five (5) business days of the request in compliance with the requirement
of Section 6.1 below. In the event of a termination for Cause, written confirmation shall specify the subsection(s) of the definition
of Cause relied on to support the decision to terminate.

 

5.7 Cooperation With
Company After Termination of Employment. Following termination of Employee’s employment for any reason,
Employee shall fully cooperate with the Company in all matters relating to the winding up of Employee’s pending work
including, but not limited to, any litigation in which the Company is involved, and the orderly transfer of any such pending
work to such other Employees as may be designated by the Company.

 

5.8 Change in Control.

 

(a) In the
event of a Change in Control (as defined below), and provided such transaction is also a “change in the ownership or effective
control of” the Company or “in the ownership of a substantial portion of the assets of” the Company, then (i)
all outstanding unvested equity awards then held by the Employee shall accelerate and vest in full; and (ii) if the Employee is
terminated on or within one (1) year following the Change in Control, then the severance in Section 5.1(b)(i) for which the
Employee will be eligible for upon a termination pursuant to Section 5.1 or 5.4 will be paid in a lump sum on the Sixtieth (60th)
day following the Separation From Service instead of on regular payroll dates during the Severance Period (with the severance
in Section 5.1(b)(ii) paid pursuant to the original schedule in that Section with no acceleration as provided for herein), and
all other provisions of Section 5.1 and 5.4, including without limitation the requirement of an effective Release to receive any
severance benefits remain the same.

    	12

    	

    

(b) If
any payment or benefit Employee would receive pursuant to a Change in Control from the Company or otherwise (the
“Payment”) would (1) constitute a “parachute payment” within the meaning of Section
280G of the Code, and (2) but for this Section, be subject to the excise tax imposed by Section 4999 of the Code (the
“Excise Tax”), and (3) immediately prior to the consummation of the Change of Control, the
Company’s stock is not readily tradable on an established securities market or otherwise and (4) the Employee agrees to
waive in a manner that satisfies Section 1.280G-1 of the Treasury Regulations that portion of the Payment that equals and
exceeds three times the Employee’s base amount (as determined in accordance with Section 1.280G-1 of the Treasury
Regulations) (such portion, the “Excess Payment”), the Company shall use its reasonable best
efforts to solicit (in a manner which satisfies all applicable requirements of such Section 280G(b)(5)(B) of the Code and the
Treasury Regulations thereunder, including Q-7 of Section 1.280G-1 of the Treasury Regulations) the vote by such number of
shareholders of the Company as is required by the terms of Section 280G(b)(5)(B) of the Code so as to render the parachute
payment provisions of Sections 280G and 4999 of the Code inapplicable to the Payment. If immediately prior to the
consummation of the Change of Control, the Company’s stock is readily tradable on an established securities market or
otherwise, or the Employee refuses to waive that portion of the Payment that constitutes the Excess Payment, then the Payment
shall be equal to the Reduced Amount. The “Reduced Amount” shall be either (x) the largest portion
of the Payment that would result in no portion of the Payment being subject to the Excise Tax or (y) the largest portion, up
to and including the total, of the Payment, whichever amount, after taking into account all applicable federal, state and
local employment taxes, income taxes, and the Excise Tax (all computed at the highest applicable marginal rate), results in
Employee’s receipt, on an after-tax basis, of the greater economic benefit notwithstanding that all or some portion of the
Payment may be subject to the Excise Tax. If a Reduced Amount will give rise to the greater after tax benefit, the reduction
in the Payments shall occur in the following order: (i) reduction of cash payments; (ii) cancellation of accelerated vesting
of equity awards other than stock options; (iii) cancellation of accelerated vesting of stock options; and (iv) reduction of
other benefits paid to Employee. Within any such category of payments and benefits (that is, (i), (ii), (iii) or (iv)), a
reduction shall occur first with respect to amounts that are not “deferred compensation” within the meaning of Code
Section 409A and then with respect to amounts that are. In the event that acceleration of compensation from Employee’s equity
awards is to be reduced, such acceleration of vesting shall be canceled, subject to the immediately preceding sentence, in
the reverse order of the date of grant.

 

(i) In the event it
is subsequently determined by the Internal Revenue Service that some portion of the Reduced Amount as determined pursuant to clause
(x) in the preceding paragraph is subject to the Excise Tax, Employee agrees to promptly return to the Company a sufficient amount
of the Payment so that no portion of the Reduced Amount is subject to the Excise Tax. For the avoidance of doubt, if the Reduced
Amount is determined pursuant to clause (y) in the preceding paragraph, Employee will have no obligation to return any portion
of the Payment pursuant to the preceding sentence.

 

(ii) Unless Employee
and the Company agree on an alternative accounting firm, the accounting firm engaged by the Company for general tax compliance
purposes as of the day prior to the effective date of the Change in Control shall perform the foregoing calculations. If the accounting
firm so engaged by the Company is serving as

    	13

    	

    

accountant or auditor for the individual,
entity or group effecting the Change in Control, the Company shall appoint a nationally recognized accounting firm to make the
determinations required hereunder. The Company shall bear all expenses with respect to the determinations by such accounting firm
required to be made hereunder.

 

(iii) The Company
shall use commercially reasonable efforts to cause the accounting firm engaged to make the determinations hereunder to provide
its calculations, together with detailed supporting documentation, to Employee and the Company within fifteen (15) calendar days
after the date on which Employee’s right to a Payment is triggered (if requested at that time by Employee or the Company) or such
other time as reasonably requested by Employee or the Company.

 

(c) “Change
in Control” means the occurrence, in a single transaction or in a series of related transactions, of any one or
more of the following events:

 

(i) any person, entity
or group (within the meaning of the Securities Exchange Act of 1934, as amended) (such person, entity, or group, an “Exchange
Act Person”),  becomes the owner, directly or indirectly, of securities of the Company representing more than fifty
percent (50%) of the combined voting power of the Company’s then outstanding securities other than by virtue of a merger,
consolidation or similar transaction;

 

(ii) there is consummated
a merger, consolidation or similar transaction involving (directly or indirectly) the Company and, immediately after the consummation
of such merger, consolidation or similar transaction, the stockholders of the Company immediately prior thereto do not own, directly
or indirectly, either (A) outstanding voting securities representing more than fifty percent (50%) of the combined outstanding
voting power of the surviving Entity in such merger, consolidation or similar transaction or (B) more than fifty percent (50%)
of the combined outstanding voting power of the parent of the surviving entity in such merger, consolidation or similar transaction;
or

 

(iii) there is
consummated a sale, lease, exclusive license or other disposition of all or substantially all of the consolidated assets of
the Company and its subsidiaries, other than a sale, lease, license or other disposition of all or substantially all of the
consolidated assets of the Company and its subsidiaries to an entity, more than fifty percent (50%) of the combined voting
power of the voting securities of which are owned by stockholders of the Company in substantially the same proportions as
their ownership of the outstanding voting securities of the Company immediately prior to such sale, lease, license or other
disposition.

 

Notwithstanding the foregoing, the term
Change in Control shall not include a sale of assets, merger or other transaction effected exclusively for the purpose of changing
the domicile of the Company.

 

5.9 Application
of Section 409A. Notwithstanding anything to the contrary set forth herein, to the extent that any payments and benefits
provided under this Agreement constitute “deferred compensation” within the meaning of Section 409A of the
Internal Revenue Code of 1986, as amended (“Code”) and the regulations and other guidance thereunder
and any

    	14

    	

    

state law of similar effect (collectively,
“Section 409A”), such payments and benefits shall not commence in connection with Employee’s termination
of employment unless and until Employee has also incurred a “separation from service” (as such term is defined in
Treasury Regulation Section 1.409A-1(h), without reference to alternative definitions thereunder, a (“Separation From
Service”), unless the Company reasonably determines that a Separation From Service is not a necessary precondition
to payment and as a result such amounts may be provided to Employee without causing Employee to incur the additional 20% tax under
Section 409A. It is intended that each installment of severance pay and benefits provided for in this Agreement is a separate
“payment” for purposes of Treasury Regulation Section 1.409A- 2(b)(2)(i). For the avoidance of doubt, it is intended
that severance payments set forth in this Agreement satisfy, to the greatest extent possible, the exceptions from the application
of Section 409A provided under Treasury Regulation Sections 1.409A-1(b)(4), l.409A-1(b)(5), and 1.409A-1(b)(9). If the Company
(or, if applicable, the successor entity thereto) determines that any payments or benefits constitute “deferred compensation”
under Section 409A and Employee is, on the termination of service, a “specified employee” of the Company or any successor
entity thereto, as such term is defined in Section 409A(a)(2)(B)(i) of the Code, then, solely to the extent necessary to avoid
the incurrence of the adverse personal tax consequences under Section 409A, the timing of the payments and benefits shall be delayed
until the earliest to occur of: (a) the date that is six months and one day after Employee’s Separation From Service, (b)
the date of Employee’s death or (c) such earlier date as is permitted under Section 409A (such applicable date, the “Specified
Employee Initial Payment Date”). On the Specified Employee Initial Payment Date, the Company (or the successor entity
thereto, as applicable) shall (i) pay to Employee a lump sum amount equal to the sum of the payments and benefits that Employee
would otherwise have received through the Specified Employee Initial Payment Date if the commencement of the payment of such amounts
had not been so delayed pursuant to this Section and (ii) commence paying the balance of the payments and benefits in accordance
with the applicable payment schedules set forth in this Agreement.

 

6. General
Provisions.

 

6.1 Notices.
Any notices required hereunder to be in writing shall be deemed effectively given: (a) upon personal delivery to the party
to be notified, (b) when sent by electronic mail, telex or confirmed facsimile if sent during normal business hours of the recipient,
and if not, then on the next business day, (c) five (5) days after having been sent by registered or certified mail, return receipt
requested, postage prepaid, or (d) one (1) day after deposit with a nationally recognized overnight courier, specifying next day
delivery, with written verification of receipt. All communications shall be sent to the Company at its primary office location
and to Employee at Employee’s address as listed on the Company payroll, or at such other address as the Company or the Employee
may designate by ten (10) days advance written notice to the other.

 

6.2 Severability.
Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under
applicable law, but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any
applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability will not affect any other provision
or any other jurisdiction, but this Agreement will be reformed,

    	15

    	

    

construed and enforced in such jurisdiction
as if such invalid, illegal or unenforceable provisions had never been contained herein.

 

6.3 Waiver.
If either party should waive any breach of any provisions of this Agreement, Employee or it shall not thereby be deemed to
have waived any preceding or succeeding breach of the same or any other provision of this Agreement.

 

6.4 Complete
Agreement. This Agreement constitutes the entire agreement between Employee and the Company with regard to the
subject matter hereof. This Agreement is the complete, final, and exclusive embodiment of their agreement with regard to this
subject matter and supersedes any prior oral discussions or written communications and agreements. This Agreement is entered
into without reliance on any promise or representation other than those expressly contained herein, and it cannot be modified
or amended except in writing signed by Employee and an authorized officer of the Company. The parties have entered into
separate stock option agreements and have or may enter into separate agreement related to stock option and/or other equity
awards. These separate agreements govern other aspects of the relationship between the parties, have or may have provisions
that survive termination of the Employee’s employment under this Agreement, may be amended or superseded by the parties
without regard to this agreement and are enforceable according to their terms without regard to the enforcement provision of
this Agreement.

 

6.5 Counterparts.
This Agreement may be executed in separate counterparts, any one of which need not contain signatures of more than one party,
but all of which taken together will constitute one and the same Agreement.

 

6.6 Headings.
The headings of the sections hereof are inserted for convenience only and shall not be deemed to constitute a part hereof
nor to affect the meaning thereof.

 

6.7 Successors
and Assigns. The Company shall assign this Agreement and its rights and obligations hereunder in whole, but not in part,
to any Company or other entity with or into which the Company may hereafter merge or consolidate or to which the Company may transfer
all or substantially all of its assets, if in any such case said Company or other entity shall by operation of law or expressly
in writing assume all obligations of the Company hereunder as fully as if it had been originally made a party hereto, but may
not otherwise assign this Agreement or its rights and obligations hereunder. The Employee may not assign or transfer this Agreement
or any rights or obligations hereunder, other than to his estate upon his death.

 

6.8 Choice of
Law. All questions concerning the construction, validity and interpretation of this Agreement will be governed by the
law of the State of Delaware. The parties agree that any litigation permitted under this Agreement, included but not limited to
litigation pursuant to Section 3 and enforcement of any arbitration award shall be brought in a state or federal court sitting
in Delaware.

 

6.9 Resolution
of Disputes. The parties recognize that litigation in federal or state courts or before federal or state administrative
agencies of disputes arising out of the Employee’s employment with the Company or out of this Agreement, or the Employee’s

    	16

    	

    

termination of employment or termination
of this Agreement, may not be in the best interests of either the Employee or the Company, and may result in unnecessary costs,
delays, complexities, and uncertainty. The parties agree that any dispute between the parties arising out of or relating to the
negotiation, execution, performance or termination of this Agreement or the Employee’s employment, including, but not limited
to, any claim arising out of this Agreement, claims under Title VII of the Civil Rights Act of 1964, as amended, the Civil Rights
Act of 1991, the Age Discrimination in Employment Act of 1967, the Americans with Disabilities Act of 1990. Section 1981 of the
Civil Rights Act of 1966, as amended, the Family Medical Leave Act, the Employee Retirement Income Security Act, and any similar
federal, state or local law, statute, regulation, or any common law doctrine, whether that dispute arises during or after employment,
shall be settled by binding arbitration in accordance with the National Rules for the Resolution of Employment Disputes of the
American Arbitration Association; provided however, that this dispute resolution provision shall not apply to Section 3
of this Agreement nor to any separate agreements between the parties that do not themselves specify arbitration as an exclusive
remedy. The location for the arbitration shall be the New York, New York metropolitan area. Any award made by such panel
shall be final, binding and conclusive on the parties for all purposes, and judgment upon the award rendered by the arbitrators
may be entered in any court having jurisdiction thereof. The arbitrators’ fees and expenses and all administrative fees
and expenses associated with the filing of the arbitration shall be borne equally by the parties unless applicable law requires
otherwise. The parties acknowledge and agree that their obligations to arbitrate under this Section survive the termination of
this Agreement and continue after the termination of the employment relationship between Employee and the Company. The parties
each further agree that the arbitration provisions of this Agreement shall provide each party with its exclusive remedy,
and each party expressly waives any right it might have to seek redress in any other forum, except as otherwise expressly provided
in this Agreement. By election arbitration as the means for final settlement of all claims, the parties hereby waive their
respective rights to, and agree not to, sue each other in any action in a Federal, State or local court with respect to such claims,
but may seek to enforce in court an arbitration award rendered pursuant to this Agreement. The parties specifically agree to waive
their respective rights to a trial by jury, and further agree that no demand, request or motion will be made for trial by jury.

 

In
Witness Whereof, the parties have executed this Employment Agreement on the day and year first written above.

 

	Everyday Health, Inc.:	 	Employee:	 
	 	 	 	 
	By: 	/s/ Alan Shapiro	 	/s/ Benjamin
    Wolin	 
	 	Name: 	Alan Shapiro	 	Benjamin Wolin	 
	 	Title:	EVP & General Counsel	 	 	 

    	17

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00226-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00226-of-00352.parquet"}]]